BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) Sees Significant Decrease in Short Interest

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) was the target of a large decline in short interest in the month of August. As of August 14th, there was short interest totaling 83 shares, a decline of 91.7% from the July 30th total of 1,000 shares. Based on an average daily volume of 14,615 shares, the short-interest ratio is currently 0.0 days. Currently, 0.0% of the shares of the company are short sold.

BioForce Nanosciences Trading Down 0.3%

Shares of BFNH opened at $3.89 on Wednesday. The firm has a fifty day simple moving average of $2.05 and a two-hundred day simple moving average of $1.16. The firm has a market cap of $130.51 million, a PE ratio of 389.39 and a beta of -0.52. BioForce Nanosciences has a 1-year low of $0.18 and a 1-year high of $4.20.

BioForce Nanosciences (OTCMKTS:BFNH) last released its quarterly earnings results on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter.

BioForce Nanosciences Company Profile

BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.

The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.